T. Rowe Price Health Sciences
Objective And StrategyObjective
Long term capital appreciation.
StrategyThe Fund normally invests at least 80% of assets in stocks of companies engaged in research, development, production, or distribution of products/services related to health care, medicine, or life sciences. While the Fund can invest in companies of any size, the majority of Fund assets are expected to be invested in large- & mid-cap companies. Allocation among pharmaceuticals, health care services companies, products & devices providers, & biotechnology firms will vary depending on the relative potential seen within each area and the outlook for the overall health sciences sector. In general, the Fund will follow a growth investment strategy, seeking companies whose earnings are expected to grow faster than inflation and the economy. When stock valuations seem unusually high, a "value" approach, which gives preference to seemingly undervalued companies, may be emphasized.